Biotechnology | CRISPR | Disease | Genomics | Therapeutics
U.S. patent appeal board ruled against University of California in CRISPR interference
On Feb. 28, 2022, the Patent and Trial Appeal Board of the U.S. Patent and Trademark Office (USPTO)…